Ichnos Sciences SA

Swiss Biotech Association

Member

Our R&D center for biologics in Switzerland has end-to-end capabilities to discover Novel Biological Entities (NBEs) and develop them from inception through to pre-clinical & clinical studies. It is also fully equipped to manufacture clinical trial-size batch materials.

Location

Chemin de la Combeta 5, 2300 La Chaux-de-Fonds, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2004
Number of employees in Switzerland

150-249

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
Mendrisio

Member

Labatec Pharma SA

Labatec is a privately owned Swiss-based pharmaceutical company with more than 50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.
Meyrin

Member

GlycoEra AG

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
8952 Schlieren

Member